1. US Department of Justice. Promoting pain relief and preventing abuse of pain medications: a critical balancing act. 2012. http://www.deadiversion.usdoj.gov/pubs/advisories/painrelief.pdf . Accessed 6 Apr 2012.
2. Centers for Disease Control and Prevention. Vital signs: overdoses of prescription opioid pain relievers—United States, 1999–2008. MMWR Wkly. 2011;60(43):1487–92.
3. Office of National Drug Control Policy. Prescription drug abuse. 2012. http://www.whitehouse.gov/ondcp/prescription-drug-abuse . Accessed 28 Mar 2012.
4. US Food and Drug Administration. Approved Risk Evaluation and Mitigation Strategies (REMS). 2012. http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm111350.htm . Accessed 5 Oct 2012.
5. Craig DS. The Food and Drug Administration risk evaluation and mitigation strategy. J Pain Palliat Care Pharmacother. 2010;24(2):145–8.